MetaCap

Aptevo Therapeutics Insider Trades

NASDAQ: APVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.79-0.01 (-0.56%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $20.13K
Sales
0 · $0
Shares bought / sold
13.51K / 0
Net activity
Net buying $20,134

Aptevo Therapeutics insider activity

Over the last 12 months, Aptevo Therapeutics insiders reported 14 transactions on SEC Form 4: 1 open-market purchase and 0 sales. Insiders bought $20,134 and sold $0 worth of stock, for net insider buying of $20,134. The most recent filing shows Harsanyi Zsolt (Director) reporting a transaction in 400 shares on Aug 6, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put APVO's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

APVO insider transactions

Aptevo Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Aug 6, 2026Niederhuber JohnDirectorOption exercise400—Form 4
Aug 6, 2026Kunz Barbara LopezDirectorOption exercise400—Form 4
Aug 6, 2026White Marvin LExecutive ChairTax withholding406$1.65KForm 4
Aug 6, 2026White Marvin LExecutive ChairOption exercise1,666—Form 4
Aug 6, 2026Kwon SoYoungSVP, GC, BD & Corp AffairsOption exercise638—Form 4
Aug 6, 2026Taylor DaphneSVP, CFOOption exercise638—Form 4
Aug 6, 2026Abdun-Nabi DanielDirectorOption exercise400—Form 4
Aug 6, 2026Grant Grady IIIDirectorOption exercise400—Form 4
Aug 6, 2026Huebner DirkSVP, CMOTax withholding156$634.92Form 4
Aug 6, 2026Huebner DirkSVP, CMOOption exercise638—Form 4
Aug 6, 2026Lamothe Jeffrey G.President and CEOOption exercise961—Form 4
Aug 6, 2026Harsanyi ZsoltDirectorOption exercise400—Form 4
Jul 17, 2026White Marvin LExecutive ChairOption exercise1—Form 4
Nov 10, 2025Grant Grady IIIDirectorBuy13,513$20.13KForm 4
Jul 17, 2025Lamothe Jeffrey G.EVP, COOOption exercise5—Form 4
Jul 17, 2025White Marvin LPresident and CEOOption exercise10—Form 4
Jul 17, 2025Kwon SoYoungSVP, GC, BD & Corp AffairsOption exercise3—Form 4
Jul 17, 2025Niederhuber JohnDirectorOption exercise1—Form 4
Jul 17, 2025Kunz Barbara LopezDirectorOption exercise1—Form 4
Jul 17, 2025Taylor DaphneSVP, CFOOption exercise3—Form 4
Jul 17, 2025Harsanyi ZsoltDirectorOption exercise1—Form 4
Jul 17, 2025Grant Grady IIIDirectorOption exercise1—Form 4
Jul 17, 2025Abdun-Nabi DanielDirectorOption exercise1—Form 4
Mar 4, 2025Taylor DaphneSVP, CFOOption exercise1—Form 4
Mar 3, 2025White Marvin LPresident and CEOOption exercise6—Form 4
Mar 3, 2025Lamothe Jeffrey G.EVP, COOOption exercise2—Form 4
Mar 3, 2025Kwon SoYoungSVP, GC, BD & Corp AffairsOption exercise2—Form 4
Mar 2, 2025Taylor DaphneSVP, CFOOption exercise2—Form 4
Mar 2, 2025White Marvin LPresident and CEOOption exercise8—Form 4
Mar 2, 2025Lamothe Jeffrey G.EVP, COOOption exercise3—Form 4
Mar 2, 2025Kwon SoYoungSVP, GC, BD & Corp AffairsOption exercise2—Form 4
Aug 8, 2024Lamothe Jeffrey G.EVP, COOOption exercise272—Form 4
Aug 8, 2024Lamothe Jeffrey G.EVP, COOOption exercise42—Form 4
Aug 8, 2024Taylor DaphneSVP, CFOOption exercise158—Form 4
Aug 8, 2024Kwon SoYoungSVP, GC, BD & Corp AffairsOption exercise213—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related